Extracellular Vesicle-Based Therapeutics: Preclinical and Clinical Investigations

Drug nanoformulations hold remarkable promise for the efficient delivery of therapeutics to a disease site. Unfortunately, artificial nanocarriers, mostly liposomes and polymeric nanoparticles, show limited applications due to the unfavorable pharmacokinetics and rapid clearance from the blood circu...

Descripción completa

Detalles Bibliográficos
Autores principales: Klyachko, Natalia L., Arzt, Camryn J., Li, Samuel M., Gololobova, Olesia A., Batrakova, Elena V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760239/
https://www.ncbi.nlm.nih.gov/pubmed/33271883
http://dx.doi.org/10.3390/pharmaceutics12121171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760239/
https://www.ncbi.nlm.nih.gov/pubmed/33271883
http://dx.doi.org/10.3390/pharmaceutics12121171

Ejemplares similares